Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 5979-5984

  Rubins, Jeffrey B ^a,b,c   Alter, Michael ^a,b   Loch, Joyce ^a   Janoff, Edward N ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0032734524     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.5979-5984.1999     Document Type: Article

References (34)

1. Ammann, A. J., G. Schiffman, and R. Austrian. 1980. The antibody response to pneumococcal capsular polysaccharides in aged individuals. Proc. Soc. Exp. Biol. Med. 164:312-316.
2. Bolan, G., C. V. Broome, R. R. Facklam, B. D. Plikaytis, D. W. Fraser, and W. F. Schlech III. 1986. Pneumococcal vaccine efficacy in selected populations in the United States. Ann. Intern. Med. 104:1-6.
3. Butler, J. C., R. F. Breiman, J. F. Campbell, H. B. Lipman, C. V. Broome, and R. R. Facklam. 1993. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 270:1826-1831.
4. Butler, J. C., J. Hofmann, M. S. Cetron, J. A. Elliott, R. R. Facklam, and R. F. Breiman. 1996. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J. Infect. Dis. 174:986-993.
5. Carson, P.J., R. L. Schut, M. L. Simpson, J. O'Brien, and E. N. Janoff. 1995. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J. Infect. Dis. 172:340-345.
6. Concepcion, N., and C. E. Frasch. 1998. Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization. Clin. Diagn. Lab. Immunol. 5:199-204.
7. Coughlin, R. T., A. C. White, C. A. Anderson, G. M. Carlone, D. L. Klein, and J. Treanor. 1998. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine 16:1761-1767.
8. Fata, F. T., B. C. Herzlich, G. Schiffman, and A. L. Ast. 1996. Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels. Ann. Intern. Med. 124:299-304.
9. Forrester, H. L., D. W. Jahnigen, and F. M. LaForce. 1987. Inefficacy of pneumococcal vaccine in a high-risk population. Am. J. Med. 83:425-430.
10. Go, E. S., and Z. K. Ballas. 1996. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J. Allergy Clin. Immunol. 98:205-215.
11. Hedlund, J. U., M. E. Kalin, A. B. Ortqvist, and J. Henrichsen. 1994. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Arch. Intern. Med. 154:1961-1965.
12. Hilleman, M. R., A. J. Carlson, Jr., A. A. McLean, P. P. Vella, R. E. Weibel, and A. F. Woodhour. 1981. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev. Infect. Dis. 3(Suppl.):S31-S42.
13. Hofmann, J., M. S. Cetron, M. M. Farley, W. S. Baughman, R. R. Facklam, J. A. Elliott, K. A. Deaver, and R. F. Breiman. 1995. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333: 481-486.
14. Koivula, I., M. Stén, M. Leinonen, and P. H. Mäkelä, 1997. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am. J. Med. 103:281-290.
15. Konradsen, H. B. 1995. Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. Clin. Infect. Dis. 21:616-620.
16. Lee, C. J., S. D. Banks, and J. P. Li. 1991. Virulence, immunity, and vaccine related to Streptococcus pneumoniae. Crit. Rev. Microbiol. 18:89-114.
17. Lexau, C., R. Lynfield, and R Danila. (Minnesota Department of Health). Personal communication.
18. Lovgren, M., J. S. Spika, and J. A. Talbot. 1998. Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995. Can. Med. Assoc. J. 158:327-331.
19. Musher, D. M., J. E. Groover, E. A. Graviss, and R. E. Baughn. 1996. The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin. Infect. Dis. 22:165-167.
20. Musher, D. M., J. E. Groover, D. A. Watson, J. P. Pandey, M. C. Rodriguez-Barradas, R. E. Baughn, M. S. Pollack, E. A. Graviss, M. deAndrade, and C. L. Amos. 1997. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J. Investig. Med. 45:57-68.
21. Örtqvist, Å., J. Hedlund, L. Å. Burman, E. Elbel, M. Höfer, M. Leinonen, I. Lindblad, B. Sundelöf, M. Kalin, and Swedish Pneumococcal Vaccination Study Group. 1998, Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 351:399-403.
22. Parkinson, A. J., M. Davidson, M. A. Fitzgerald, L. R. Bulkow, and D. J. Parks. 1994. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990. J. Infect. Dis. 170:461-464.
23. Plouffe, J. F., S. K. Moore, R. Davis, and R. R. Facklam. 1994. Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio. J. Clin. Microbiol. 32:1606-1607.
24. Quataert, S. A., C. S. Kirch, L. J. Quackenbush Wiedl, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
25. Roghmann, K. J., P. A. Tabloski, D. W. Bentley, and G. Schifman. 1987. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J. Gerontol. 42:265-270.
26. Ruben, F. L., and M. Uhrin. 1985. Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine. J. Infect. Dis. 151:845-849.
27. Rubins, J. B., A. K. G. Puri, J. Loch, D. Charboneau, R. MacDonald, N. Opstad, and E. N. Janoff. 1998. Magnitude, duration, quality and function of pneumococcal vaccine responses in elderly adults. J. Infect. Dis. 178:431-440.
28. Sankilampi, U., P. O. Honkanen, A. Bloigu, E. Herva, and M. Leinonen. 1996. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J. Infect. Dis. 173:387-393.
29. Sankilampi, U., R. Isoaho, A. Bloigu, S. L. Kivela, and M. Leinonen. 1997. Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly populalion. Int. J. Epidemiol. 26:420-427.
30. Shapiro, E. D., A. T. Berg, R. Austrian, D. Schroeder, V. Parcells, A. Margolis, R. K. Adair, and J. D. Clemens. 1991. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1453-1460.
31. Shapiro, E. D., and J. D. Clemens. 1984. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann. Intern. Med. 101:325-330.
32. Simberkoff, M. S., A. P. Cross, M. Al-Ibrahim, A. L. Baltch, P. J. Geiseler, J. Nadler, A. S. Richmond, R. P. Smith, G. Schiffman, D. S. Shepard, and J. P. Van Eeckhout. 1986. Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative study. N. Engl. J. Med. 315:1318-1327.
33. Sims, R. V., W. C. Steinmann, J. H. McConville, L. R. King, W. C. Zwick, and J. S. Schwartz. 1988. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann. Intern. Med. 108:653-657.
34. Vióarsson, G., I. Jónsdóttir, S. Jónsson, and H. Valdimarsson. 1994. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. J. Infect. Dis. 170:592-599.